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Abstract
Previously we showed that preincubation of cells with ferric ammonium citrate (FAC) resulted in a marked increase in Fe
uptake from both 59Fe-transferrin (Tf) and 59Fe-citrate (D.R. Richardson, E. Baker, J. Biol. Chem. 267 (1992) 13972^13979;
D.R. Richardson, P. Ponka, Biochim. Biophys. Acta 1269 (1995) 105^114). This Fe uptake process was independent of the
transferrin receptor and appeared to be activated by free radicals generated via the iron-catalysed Haber-Weiss reaction. To
further understand this process, the present investigation was performed. In these experiments, cells were preincubated for 3 h
at 37‡C with FAC or metal ion solutions and then labelled for 3 h at 37‡C with 59Fe-Tf. Exposure of cells to FAC resulted in
Fe uptake from 59Fe-citrate that became saturated at an Fe concentration of 2.5 WM, while FAC-activated Fe uptake from Tf
was not saturable up to 25 WM. In addition, the extent of FAC-activated Fe uptake from citrate was far greater than that
from Tf. These results suggest a mechanism where FAC-activated Fe uptake from citrate may result from direct interaction
with the transporter, while Fe uptake from Tf appears indirect and less efficient. Preincubation of cells with FAC at 4‡C
instead of 37‡C prevented its effect at stimulating 59Fe uptake from 59Fe-Tf, suggesting that an active process was involved.
Previous studies by others have shown that FAC can increase ferrireductase activity that may enhance 59Fe uptake from
59Fe-Tf. However, there was no difference in the ability of FAC-treated cells compared to controls to reduce ferricyanide to
ferrocyanide, suggesting no change in oxidoreductase activity. To examine if activation of this Fe uptake mechanism could
occur by incubation with a range of metal ions, cells were preincubated with either FAC, ferric chloride, ferrous sulphate,
ferrous ammonium sulphate, gallium nitrate, copper chloride, zinc chloride, or cobalt chloride. Stimulation of 59Fe uptake
from Tf was shown (in order of potency) with ferric chloride, ferrous sulphate, ferrous ammonium sulphate, and gallium
nitrate. The other metal ions examined decreased 59Fe uptake from Tf. The fact that redox-active Cu(II) ion did not stimulate
Fe uptake while redox-inactive Ga(III) did, suggests a mechanism of transporter activation not solely dependent on free
radical generation. Indeed, the activation of Fe uptake appears dependent on the presence of the Fe atom itself or a metal ion
with atomic similarities to Fe (e.g. Ga). ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Under physiological conditions virtually all iron
(Fe) in the serum is bound to the Fe-binding protein,
transferrin (Tf) (for reviews see [1,2]). In erythroid
precursors such as reticulocytes, Tf donates its Fe
to cells via its speci¢c binding to the Tf receptor
(TfR) on the cell membrane [2]. The Tf-TfR complex
is then internalised by receptor-mediated endocytosis
(RME) [1,2]. The Fe is released from Tf by a de-
crease in endosomal pH and is then transported
through the membrane by Nramp2 (also known as
the divalent metal ion transporter 1 (DMT1) or di-
valent cation transporter 1 (DCT1)) [3^5]. Apart
from the well characterised RME process, a second
mechanism of Fe uptake from Tf has been reported
in rat hepatocytes [6^9], human melanoma cells
[10,11], and human hepatoma cells [12]. In some of
these studies an extracellular reductive process medi-
ated by an oxidoreductase [13] was thought to be
involved in the second mechanism [8,9]. In contrast,
in other investigations an endocytotic or pinocytotic
process was proposed [6,7,11]. Apart from these
mechanisms, recent investigations have suggested
that Fe uptake from Tf may also be mediated by
the transferrin receptor 2 (TfR2), although the phys-
iological signi¢cance of this molecule remains unclear
[14,15].
Apart from Fe uptake from Tf, many cell types
have also been shown to e⁄ciently take up Fe
from small molecular weight (Mr) complexes by a
high capacity transport system ([16^19]; for review
see [2]). Little is known concerning the molecular
mechanisms involved in Fe uptake from low Mr
complexes, most studies describing saturable Fe up-
take with di¡erent but generally low Km [17,18]. Pre-
incubation of cells with the Fe complex ferric ammo-
nium citrate (FAC) resulted in a marked increase in
Fe uptake from Fe-nitrilotriacetic acid (Fe-NTA)
complexes [19]. Results from this latter study sug-
gested that this involved recruitment of transporters
from an internal pool to the cell surface [19]. This
observation was of importance, as ferric citrate is
found in the serum of patients with Fe-overload dis-
ease [20], and may contribute to Fe accumulation
within the liver and other organs [2].
Apart from the e¡ect of FAC on stimulating Fe
uptake from low Mr complexes, it was also of inter-
est to ¢nd that incubation of melanoma cells with
FAC had two e¡ects on Fe uptake from Tf [21].
First, at Tf concentrations up to saturation of the
TfR, Fe uptake from Tf was decreased due to the
downregulation of the speci¢c Tf-binding site. Sec-
ond, at Tf concentrations higher than that required
for saturation of the TfR, a marked increase in Fe
uptake occurred [21]. A more recent study demon-
strated that this latter process was not mediated by
the TfR, and that 59Fe uptake from 59Fe-citrate
could also be markedly enhanced after preincubation
with FAC [22]. The addition of a range of free rad-
ical scavengers to FAC markedly depressed FAC-ac-
tivated Fe uptake from Tf and Fe-citrate, whereas
when these agents were added to control cells they
had no e¡ect [22]. The addition of hydrogen peroxide
or superoxide-generating agents to FAC also stimu-
lated Fe uptake, whereas little e¡ect was found when
these agents were added to medium alone [22]. These
results suggested that activation of the FAC-stimu-
lated Fe uptake mechanism was caused by the pro-
duction of hydroxyl radicals via the Fe-catalysed
Haber-Weiss reaction. It was hypothesised that this
Fe uptake process may represent a defense mecha-
nism against oxidant stress generated in the presence
of low Mr complexes [22]. Additional studies using
primary cultures of hepatocytes demonstrated that
there was a marked increase in Fe uptake from
both Tf and Fe-citrate after incubation with FAC
[23]. These data may help explain the loading of he-
patocytes with Fe that occurs in Fe-overload disease
despite marked downregulation of the TfR [23].
In the present study we have further characterised
the FAC-stimulated Fe uptake mechanism. Our stud-
ies demonstrate that FAC-stimulated 59Fe uptake
from 59Fe-Tf increased biphasically as a function of
Tf concentration up to 1 mg/ml ([Fe] = 25 WM). In
contrast, internalised 59Fe uptake from 59Fe-citrate
became saturated at an Fe concentration of 2.5 WM.
Further studies demonstrated that incubation of cells
with FAC at 4‡C instead of 37‡C prevented the stim-
ulation of 59Fe uptake observed, suggesting that an
active process was involved. In contrast to previous
studies which showed that incubation with FAC
stimulates oxidoreductase activity, no change was
observed in the ability of cells to reduce the oxido-
reductase substrate ferricyanide. These studies sug-
gest that the increase in Fe uptake after preincuba-
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tion with FAC was not due to enhancement of oxi-
doreductase activity. Preincubation of cells with a
range of metal ions indicated that Fe uptake from
Tf was not only stimulated by FAC, but also by
other Fe salts and to a lesser extent Ga. In contrast
to Fe, other biologically signi¢cant metal ions (e.g.
Cu(II) and Zn(II)) did not stimulate Fe uptake from
Tf, and actually depressed this process.
2. Materials and methods
2.1. Materials
Iron-59 (as ferric chloride in 0.1 M HCl) was pur-
chased from Dupont, NEN products (Boston, MA,
USA). Eagle’s modi¢ed minimum essential medium
(MEM), Hanks’ balanced salt solution (BSS), and
penicillin-streptomycin were obtained from Gibco
(Grand Island, NY, USA). Human Tf was obtained
from Sigma (St. Louis, MO, USA). Pronase was pur-
chased from Boehringer-Mannheim (Mannheim,
Germany). Non-essential amino acids (100U concen-
trate) and fetal calf serum (FCS) were obtained from
ICN (CA, USA). Fungizone (amphotericin B) was
obtained from Squibb (Montreal, Canada). Ferric
ammonium citrate (17.5% Fe) was obtained from
Aldrich (Sydney, Australia). All other chemicals
were of analytical reagent quality.
2.2. Cells
The SK-Mel-28 human malignant melanoma cell
line was obtained from the American Type Culture
Collection (ATCC, Rockville, MD, USA). The SK-
Mel-28 line was used as the e¡ect of FAC on Fe
uptake has previously been examined using these
cells and their Fe metabolism is well characterised
[10,11,21,22]. Cells were subcultured and used for
experiments as described by Richardson and Baker
[10]. Procedures used to check cell viability and de-
di¡erentiation were the same as reported previously
[10].
2.3. Protein puri¢cation and labelling
Human apoTf was prepared and labelled with 59Fe
to produce diferric Tf, as described [10]. Unbound
59Fe was removed by exhaustive vacuum dialysis
against NaCl (0.15 M) adjusted to pH 7.4 with
1.4% sodium bicarbonate. The saturation of Tf
with Fe was monitored by UV-Vis spectrophotome-
try with the absorbance at 280 nm (protein) being
compared with that at 465 nm (Fe-binding site). In
all studies, fully saturated diferric Tf was used.
2.4. Experimental procedure: uptake of iron and
transferrin after exposure to ferric ammonium
citrate
2.4.1. Preincubation procedure
After 24 h on the petri dish, near con£uent mono-
layers of cells were washed to remove bovine Tf from
FCS using three separate 30 min incubations in
MEM at 37‡C. The cells were then preincubated
with MEM (control) or MEM containing FAC
(25 Wg/ml; [Fe] = 4 Wg/ml) for 3 h at 37‡C. We have
used FAC in these studies as Fe-citrate is found in
the serum of patients with Fe-overload disease [20].
Hence, this complex has pathophysiological rele-
vance. Also, FAC has been shown to e⁄ciently sup-
ply Fe to physiological pools, resulting in downregu-
lation of the TfR [21] and donation of Fe to ferritin
[24]. As detailed in our previous studies [22,23], the
low concentrations of FAC used in the present stud-
ies had no e¡ect on cellular viability as judged by
phase-contrast microscopy, Trypan blue staining,
and the adherence of cells to the culture substratum.
Further, the addition of FAC to the culture medium
had no e¡ect on its pH. In some experiments the
ability of FAC to increase 59Fe uptake from 59Fe-
Tf was compared to a variety of metal ions added to
the control medium. For all studies, FAC and the
metal ion solutions were prepared in MEM immedi-
ately prior to the experiment.
2.4.2. Labelling procedure
After the preincubation procedure, the medium
was removed and then replaced with medium con-
taining 59Fe-Tf ([Tf] = 0.002^1 mg/ml; [Fe] = 0.05^
25 WM) or 59Fe-citrate (1:100; [Fe] = 0.05^5 WM)
which was then incubated with the cells for 3 h at
37‡C [22,25]. Previous studies investigating low Mr
Fe uptake have used nitrilotriacetic acid (NTA) to
chelate 59Fe [26]. However, NTA is not physiologi-
cally relevant, and in the present investigation 59Fe-
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citrate was used, as this is the prevailing form of
non-Tf-bound Fe in the serum of Fe-overloaded pa-
tients [20]. In addition, previous studies in melanoma
cells have demonstrated that 59Fe donated to the cell
from citrate-59Fe complexes is e⁄ciently internalised
and incorporated into ferritin and other subcellular
compartments [25].
After incubation with 59Fe-Tf or 59Fe-citrate, the
petri dishes were placed on ice, the medium removed,
and the cell monolayer washed four times with ice-
cold BSS. Pronase (1 mg/ml) was then incubated
with the cells for 30 min at 4‡C to separate internal-
ised (pronase-resistant) from membrane-bound (pro-
nase-sensitive) 59Fe using established techniques
[21,27]. Control experiments in our previous studies
have shown that this technique is appropriate to
measure internalised and membrane-bound 59Fe
[10,25,28]. Radioactivity was measured using a
Q-scintillation counter (1282 Compugamma; LKB
Wallace, Turku, Finland).
Results were calculated as moles of Fe or Tf per
gram of protein (gPR) or as a percentage of the
control and are expressed as mean or mean þ S.D.
Each determination was derived from one con£uent
petri dish containing 5U106 cells, and this was equiv-
alent to approx. 0.45 mg of protein via the bicincho-
ninic acid protein assay procedure [10].
2.5. Oxidoreductase activity assay
To determine if preincubation of cells with FAC
could increase oxidoreductase activity, and therefore
Fe uptake, we determined the reduction of the clas-
sical oxidoreductase substrate ferricyanide [13]. In
this study we examined the reduction of ferricyanide
to ferrocyanide using procedures described by Avron
and Shavit [29] and Inman et al. [30]. The cells were
grown to near con£uence on 25 cm2 culture £asks
and washed using three separate 30 min incubations
at 37‡C. They were then preincubated with MEM
(control) or MEM containing FAC (25 Wg/ml) for
3 h at 37‡C. Cells were then incubated with ferricya-
nide (50 WM) in phenol red free BSS for 2 or 3 h at
either 4‡C or 37‡C. The measurements at 4‡C were
used to assess non-speci¢c ferricyanide reductase ac-
tivity [30]. After the incubation with ferricyanide,
1 ml of the medium overlying the cells was sampled
and then centrifuged at 14 000 rpm for 1 min. A
700 Wl aliquot of the supernatant was transferred to
a cuvette and the following reagents then sequen-
tially added: 100 Wl of sodium acetate (3 M, pH
6.4), 100 Wl of citric acid (0.2 M), 50 Wl of batho-
phenanthroline disulphonate (3.34 mg/ml), and 50 Wl
of FeCl3 (3.3 mM freshly prepared in 0.1 M acetic
acid) [30]. The solutions were then well mixed and
the absorbance measured at 535 nm after 1 h to
allow for colour development [30]. All spectrophoto-
metric readings were performed using a Beckman
DU 640 UV-Vis spectrophotometer (Beckman In-
struments, CA, USA).
2.6. Statistics
Experimental data were compared using Student’s
t-test. Results were considered statistically signi¢cant
when P6 0.05.
3. Results
3.1. The e¡ect of diferric transferrin or citrate
concentration on FAC-activated iron uptake
After preincubation of SK-Mel-28 melanoma cells
with FAC (25 Wg/ml) for 3 h at 37‡C, internalised
59Fe uptake from 59Fe-Tf increased biphasically as a
function of Tf concentration up to 1 mg/ml ([Fe] = 25
WM) and did not plateau (Fig. 1A). Iron uptake into
the pronase-sensitive membrane compartment also
increased as a function of Tf concentration (Fig.
1B). The e¡ect of FAC at increasing membrane-
bound 59Fe uptake was observed at all Tf concentra-
tions (Fig. 1B). This is in contrast to internalised
59Fe uptake, where FAC only increased 59Fe uptake
at Tf concentrations of 0.1 mg/ml or greater (Fig.
1A). These observations may indicate the 59Fe label-
ling of a membrane-bound molecule involved in
FAC-activated Fe transport prior to the increase ob-
served in internalised 59Fe uptake. As described pre-
viously, preincubation of cells with citrate alone did
not stimulate 59Fe uptake from 59Fe-Tf [22].
In contrast to the FAC-induced increase in inter-
nalised 59Fe uptake from 59Fe-Tf (Fig. 1A), internal-
ised 59Fe uptake from 59Fe-citrate plateaued at an Fe
concentration of approx. 2.5 WM (Fig. 2A). Further-
more, the extent of the increase in 59Fe uptake after
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preincubation with FAC was far greater in cells la-
belled with 59Fe-citrate compared to those labelled
with 59Fe-Tf. For example, at an Fe concentration
of 5 WM, 59Fe-citrate uptake was over 20-fold that
obtained when cells were preincubated with MEM
(Fig. 2A). For comparison, when cells were labelled
with 59Fe-Tf at the highest Fe concentration of
25 WM, FAC-activated 59Fe uptake from Tf in-
creased 7-fold (Fig. 1A). Similarly to internalised
59Fe uptake from 59Fe-citrate (Fig. 2A), membrane
59Fe uptake from this complex also plateaued at ap-
prox. 2.5 WM (Fig. 2B), suggesting this process was
saturable.
3.2. E¡ect of preincubation and labelling temperature
on FAC-activated iron uptake from transferrin
Further experiments examined whether the FAC-
activated Fe uptake mechanism was temperature-de-
pendent (Fig. 3). Previous studies have clearly dem-
onstrated that Fe uptake from Tf via RME is a tem-
Fig. 2. The e¡ect of 59Fe-citrate concentration on FAC-acti-
vated iron uptake by SK-Mel-28 melanoma cells. The cells were
washed and subsequently preincubated for 3 h at 37‡C with
FAC (25 Wg/ml) or MEM only and then labelled with 59Fe-cit-
rate ([Fe] = 0.05^5 WM) for 3 h at 37‡C. The cells were then
washed four times with ice-cold BSS and incubated for 30 min
at 4‡C with the protease, pronase (1 mg/ml), to separate (A) in-
ternalised 59Fe from (B) membrane-bound 59Fe. The results il-
lustrated are means of duplicate determinations in a typical ex-
periment of three separate experiments performed.
Fig. 1. The e¡ect of 59Fe-transferrin concentration on FAC-ac-
tivated iron uptake by SK-Mel-28 cells. The cells were washed
and subsequently preincubated for 3 h at 37‡C with FAC
(25 Wg/ml) or MEM only and then labelled with 59Fe-Tf
(0.002^1 mg/ml; [Fe] = 0.05^25 WM) for 3 h at 37‡C. The cells
were then washed four times with ice-cold BSS and incubated
for 30 min at 4‡C with the protease, pronase (1 mg/ml), to sep-
arate (A) internalised 59Fe from (B) membrane-bound 59Fe. In-
set in B shows membrane-bound 59Fe uptake between 59Fe-Tf
concentrations of 0.002 and 0.02 mg/ml ([Fe] = 0.05^0.5 WM).
The results illustrated are means of duplicate determinations in
a typical experiment of three separate experiments performed.
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perature- and energy-dependent process [1]. How-
ever, nothing is known concerning FAC-activated
Fe uptake from Tf. In the present experiments, cells
were preincubated with MEM or FAC at 4‡C or
37‡C and then labelled with 59Fe-Tf at 4‡C or 37‡C
(Fig. 3). Preincubation of cells with FAC at 4‡C
followed by labelling with 59Fe-Tf at 37‡C totally
prevented the stimulation of 59Fe uptake observed
when cells were preincubated and labelled at 37‡C
(Fig. 3). In addition, when cells were preincubated
with FAC at 37‡C and then labelled with 59Fe-Tf at
4‡C, again no stimulation of 59Fe uptake from 59Fe-
Tf was found (Fig. 3). These results suggested that
the FAC-stimulated Fe uptake process was an active
temperature-dependent mechanism.
Studies were initiated to examine the e¡ect of a
range of metabolic inhibitors on FAC-activated
59Fe uptake from 59Fe-Tf (data not shown). How-
ever, the results were di⁄cult to interpret because
when inhibitors (e.g. 2,4-dinitrophenol) were added
to FAC, they may not only be acting to reduce ATP
levels, but could also be directly reacting with FAC
to in£uence the result.
3.3. Is FAC-activated iron uptake mediated by
stimulation of a cell surface oxidoreductase?
Previous studies by others suggested that FAC
could stimulate cell surface oxidoreductase activity
[31,32]. Such a mechanism could possibly explain
the ability of FAC to increase 59Fe uptake from
59Fe-Tf. To test this hypothesis, cells were preincu-
bated with FAC for 3 h at 37‡C and oxidoreductase
activity measured by assessing the reduction of the
standard oxidoreductase substrate ferricyanide at
4‡C or 37‡C for 2 or 3 h [13] (Fig. 4). The measure-
ments at 4‡C were relevant controls to determine the
amount of non-speci¢c ferricyanide reduction that is
not due to active cellular oxidoreductase activity [30].
Reduction of ferricyanide at 37‡C was always greater
Fig. 3. The e¡ect of preincubation or labelling temperature on iron uptake from transferrin by the FAC-activated iron uptake mecha-
nism by SK-Mel-28 melanoma cells. Cells were washed and subsequently preincubated with FAC (25 Wg/ml) or control medium
(MEM) alone for 3 h at 4‡C or 37‡C and then labelled at 4‡C or 37‡C for 3 h with 59Fe-transferrin (0.1 mg/ml; [Fe] = 2.5 WM). The
cells were then washed and internalised 59Fe uptake determined using a 30 min incubation at 4‡C with the protease pronase (1 mg/ml).
The results shown are mean þ S.D. of three determinations in a typical experiment of three separate experiments performed.
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than that found at 4‡C (Fig. 4). However, compared
to the relevant control, preincubation with FAC had
no signi¢cant e¡ect (Ps 0.05) on the reduction of
ferricyanide after 2 or 3 h (Fig. 4). These data sug-
gest that FAC was not stimulating oxidoreductase
activity and increasing 59Fe uptake from 59Fe-Tf by
this mechanism. However, from the current data we
cannot exclude that the reductase activity observed
plays some role in Fe transport.
3.4. The e¡ect on iron uptake from transferrin of
preincubation of cells with a range of metal ions
To further examine the mechanism of the FAC-
activated Fe uptake, cells were incubated with a
range of metal salts (25^200 WM) including ferric
chloride (FeCl3), ferrous sulphate (FeSO4), ferrous
ammonium sulphate (FAS), gallium nitrate
(Ga(NO3)3), copper chloride (CuCl2), zinc chloride
(ZnCl2), or cobalt chloride (CoCl2), and the results
compared to FAC (Fig. 5). At the concentrations of
metal ions tested, no precipitation was evident during
the experiment. Previous studies have used metal ion
concentrations from 0.5 mM up to 1 mM to examine
their e¡ect on metal transport [26,33]. However, in
our hands, concentrations greater than 200 WM were
found to be cytotoxic and/or resulted in precipita-
tion, and so were not used. In the case of the Fe
salts, the high concentrations of natural chelators
within MEM (e.g. amino acids, phosphate etc.) was
su⁄cient to prevent precipitation of high Mr Fe hy-
droxide species.
The three most e¡ective metal ions at increasing
59Fe uptake from 59Fe-Tf were (in descending order)
FeCl3, FeSO4, and FAS (Fig. 5). At an Fe concen-
tration of 200 WM, each of these metal salts increased
59Fe uptake from 59Fe-Tf by approx. 250%, 200%,
and 175% of the control value respectively (Fig. 5).
In contrast, preincubation with FAC resulted in a
biphasic response resulting in an initial increase in
59Fe uptake to over 150% of the control at 50 WM,
followed by a subsequent decrease in 59Fe uptake as
Fig. 4. The e¡ect of preincubation with FAC on the ability of cells to reduce the oxidoreductase substrate ferricyanide. The SK-Mel-
28 melanoma cells were washed and subsequently preincubated for 3 h with control medium or FAC (25 Wg/ml) at 37‡C. The cells
were then washed, and their ability to reduce ferricyanide examined by incubation with this compound at 4‡C or 37‡C for 2 or 3 h
(for details see Section 2). The results shown are mean þ S.D. of three determinations in a typical experiment of three separate experi-
ments performed.
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the concentration increased (Fig. 5). The reason for
this biphasic response remains unclear at present, but
was not due to toxicity, as the cells remained at-
tached to the substratum and were greater than
98% viable. The only other metal ion that increased
59Fe uptake from 59Fe-Tf was Ga(NO3)3. However,
the e¡ect of this metal ion was less marked at stim-
ulating 59Fe uptake than the Fe salts, increasing 59Fe
uptake to less than 150% of the control value. The
other metal salts decreased 59Fe uptake from 59Fe-Tf
as the concentration of the metal ion increased, the
most e¡ective being ZnCl2 and CoCl2 (Fig. 5).
4. Discussion
In the present study we have further examined the
mechanism of the FAC-stimulated Fe uptake process
from Tf and Fe-citrate. To date, a variety of studies
have examined the e¡ect of FAC and metal ions on
the uptake of small Mr complexes [19,33^37]. In con-
trast, none of these investigations have examined the
mechanism involved in FAC-activated Fe uptake
from Tf. In the present study we demonstrate that
a variety of Fe salts (ferric chloride, ferrous ammo-
nium sulphate and ferrous sulphate), and to a lesser
extent Ga(NO3)3, are e¡ective at increasing Fe up-
take from Tf. In contrast, other metal ions including
Zn(II), Co(II), or Cu(II) inhibit Fe uptake. The e¡ect
of these Fe and Ga salts at increasing 59Fe uptake
from 59Fe-Tf has not been reported previously,
although there have been reports indicating that Ga
and Fe salts can stimulate Fe uptake from Fe-NTA
and other low Mr complexes [19,33,35].
Our previous studies showed that stimulation of
Fe uptake from either Tf or Fe-citrate was linked
to the ability of Fe to generate free radicals via the
Haber-Weiss reaction [22]. Interestingly, Ga(III) can-
not redox cycle between the +2 and +3 redox states
[39] to generate free radicals. Yet, this metal can
stimulate Fe uptake from Tf, albeit less e⁄ciently
than equimolar concentrations of Fe (Fig. 5). These
results may indicate that the Fe uptake process
stimulated by Fe and Ga is via separate transport
mechanisms. Alternatively, the extent of induced
transport may be dependent on a number of factors.
For instance, while free radical production appeared
important in terms of activating the Fe uptake mech-
anism [22], it cannot be excluded that the presence of
the Fe atom itself or a metal ion with atomic sim-
ilarities to Fe may be vital for the full response.
Binding of the metal ion to an appropriate receptor
site may also be an essential component for activa-
tion. Considering this, it should be noted that an
increase in membrane Fe binding was observed after
incubation with FAC (Fig. 1B), suggesting the in-
volvement of a membrane Fe-binding molecule.
While Ga(III) does not produce free radicals in so-
lution, this cation is similar to Fe(III), and can in-
teract with Fe-binding sites in a variety of molecules
[40,41]. The fact that Ga(III) was less e¡ective than
any of the Fe salts at activating Fe transport lends
some support to a mechanism requiring several trig-
gering factors. This hypothesis is further supported
by the observation that Cu(II) which can redox cycle
had no stimulatory e¡ect on Fe uptake from Tf.
The FAC-activated Fe uptake mechanism has
been observed in a wide variety of cell types apart
from SK-Mel-28 melanoma cells, including primary
cultures of hepatocytes, myocardial cells, and ¢bro-
Fig. 5. The e¡ect of preincubating cells with a variety of metal
ions on iron uptake from 59Fe-transferrin by SK-Mel-28 mela-
noma cells. The cells were washed and subsequently preincu-
bated for 3 h at 37‡C with metal ions (25^200 WM) or control
medium only and then labelled with 59Fe-transferrin (0.1 mg/ml;
[Fe] = 2.5 WM) for 3 h at 37‡C. The cells were then washed four
times with ice-cold BSS and incubated for 30 min at 4‡C with
the protease, pronase (1 mg/ml), to separate internalised from
membrane-bound 59Fe. The results illustrated are means of du-
plicate determinations in a typical experiment of three separate
experiments performed.
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blasts, as well as many cell lines including: HeLa
cells, HL-60 cells, HepG2 hepatoma cells, Chinese
hamster ovary cells, a human embryonic kidney cell
line, and L-cells [19,22,34,36^38]. In the present
study, we have used the SK-Mel-28 melanoma cell
line as a convenient model as our previous studies
have examined the e¡ect of FAC on these cells
[21,22,42], and its Fe metabolism is well character-
ised [10,11,25]. The wide distribution of this Fe up-
take process in a variety of cell types may indicate
this mechanism has general biological relevance
rather than being a process speci¢c for a highly spe-
cialised cell type. Such a function could include a
cellular defense mechanism against redox-active Fe
complexes as suggested previously [22]. In this way,
toxic extracellular Fe would be internalised and in-
corporated into a non-toxic form within ferritin.
Experiments in the present study clearly demon-
strate the di¡erence between FAC-activated 59Fe up-
take from 59Fe-Tf and 59Fe-citrate by melanoma
cells. In the case of FAC-activated Fe uptake from
59Fe-citrate, the process is saturable as a function of
Fe concentration, and leads to a 20-fold increase in
59Fe uptake. In contrast, FAC-activated 59Fe uptake
from 59Fe-Tf is only clearly observed when the Tf
concentration is 0.1 mg/ml or above, and does not
saturate even at a Tf concentration of 1 mg/ml
([Fe] = 25 WM; Fig. 1A). This contrasts with inter-
nalised 59Fe uptake from 59Fe-citrate which saturates
at an Fe concentration of 2.5 WM. Furthermore, the
extent of stimulation of 59Fe uptake from 59Fe-Tf
after incubation with FAC was far less than that
seen with 59Fe-citrate (cf. Figs. 1A and 2A). These
studies suggest that the 59Fe-citrate complex may in-
teract directly with the transport mechanism, while
its e¡ect on Tf appears indirect. In previous studies
we showed that non-speci¢c binding of Tf to the cell
surface appeared to be essential for FAC-activated
Fe transport [22]. Further, this mechanism was
shown to be independent of the high a⁄nity TfR
[22].
Our present study demonstrates that the e¡ect of
FAC at increasing 59Fe uptake was temperature-de-
pendent (Fig. 3). These experiments showed that ac-
tive processes were involved in both the activation
event initiated by the preincubation with FAC, and
also the subsequent increase in 59Fe transport during
the labelling period. Critically, one could suggest that
FAC-activated 59Fe uptake at 37‡C may be ex-
plained by the ability of FAC to increase cell perme-
ability via membrane damage, allowing passive in£ux
of the 59Fe label. However, this is not the case, be-
cause preincubating cells with FAC at 37‡C followed
by labelling at 4‡C resulted in no enhancement of
59Fe transport (Fig. 3). Furthermore, preincubating
cells with FAC at 4‡C followed by incubation with
Tf at 37‡C did not stimulate 59Fe uptake (Fig. 3).
These latter results suggest that cellular metabolism
was essential to detect and respond to the increased
levels of extracellular Fe.
Studies examining the reduction of ferricyanide
suggested that preincubation with FAC did not en-
hance oxidoreductase activity or stimulate Fe uptake
from Tf by this mechanism. These data agree with
our previous results showing that the oxidoreductase
inhibitor, amiloride, had no e¡ect on FAC-activated
Fe uptake [22]. The role of an oxidoreductase in Fe
uptake from Tf [43] is highly controversial, and has
been challenged on both technical and theoretical
grounds [44]. However, there have been reports sug-
gesting that reduction of the FAC-Fe(III) complex to
the Fe(II) state may occur, resulting in dissociation
of the complex and the independent uptake of citrate
and Fe [35]. Our present studies indicate that ferri-
cyanide reductase activity is present on cells, and that
it does not increase after incubation with FAC.
However, we cannot exclude that the reductase ac-
tivity observed could play some role in Fe uptake.
The ¢nding that Ga or a number of Fe salts added
to MEM stimulates Fe uptake from Tf suggests that
the initial activation of this process is not dependent
on just the ferric citrate complexes found in FAC. It
should be mentioned that the addition of Fe or Ga
salts to medium will result in the formation of a wide
variety of weak complexes with medium constituents
such as amino acids and phosphate. A critical char-
acteristic for inducing Fe transport appears to be the
formation of relatively weak complexes that are la-
bile. Indeed, our previous studies showed that an
excess of the strong Fe chelator, desferrioxamine,
when added to FAC prevented its stimulatory e¡ect
on Fe transport [22].
While the molecular basis for FAC-activated Fe
uptake remains unknown, it is of interest that an
Fe-activated, P-type ATPase involved in Fe trans-
port has recently been identi¢ed [45]. In this latter
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study, ATPase-mediated Fe transport was induced
2-fold within the ¢rst 1^2 h following incubation
with FeSO4, followed by a 5-fold induction after
an 18 h incubation [45]. The ATPase was suggested
to be found in microsomes and endosomes, and may
be involved in transporting Fe released from haem
by haem oxygenase-1 [45]. Further work is required
to determine if this molecule could also be expressed
on the cell surface and have some role in FAC-acti-
vated Fe uptake.
Regarding the role of ATPases in metal ion trans-
port, it is of interest to note that another P-type
ATPase known as the Menkes protein is involved
in Cu transport and becomes redistributed from the
Golgi to the plasma membrane upon exposure to
extracellular Cu [46]. Considering that Cu and Fe
can bind to similar ligating sites [39], it could be
suggested that the Menkes protein is involved in
FAC-activated Fe uptake. However, the fact that
incubation with Cu did not result in enhanced Fe
uptake from Tf (Fig. 5) argues against this proposal.
In previous studies, Kaplan and colleagues [36] sug-
gested that the Fe transporter involved in FAC-acti-
vated Fe uptake could be due to the movement of
transporters from an internal pool to the cell surface.
Further studies examining the redistribution of the
Fe-activated P-type ATPase or other Fe transporters
(e.g. Nramp2 [3^5] and the stimulator of iron trans-
port [47]) after exposure to Fe salts appear important
in terms of understanding the molecular basis of
FAC-activated Fe uptake.
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